By proceeding, you agree to our Terms of Use and Privacy Policy.
I’m passionate about developing novel cancer therapies.
Talks About #immunetherpy
Preferred Locations #NorthAmerica
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively), there are now more than one hundred projects in the preclinical stage.